Thomas A. Davis

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry et al. · Proceedings of the National Academy of Sciences · 2003 · 1.6K citations · Full text

Life Sciences, Immunology, Oncology +17

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

F. Stephen Hodi, Martín C. Mihm, Robert J. Soiffer et al. · Proceedings of the National Academy of Sciences · 2003 · 997 citations · Full text

Life Sciences, Immunology, Oncology +17

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

Allan D. Kirk, David M. Harlan, Nicholas Armstrong et al. · Proceedings of the National Academy of Sciences · 1997 · 933 citations

Life Sciences, Immunology, Pharmacology +17

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

John M. Timmerman, Debra K. Czerwinski, Thomas A. Davis et al. · Blood · 2002 · 542 citations · Full text

Medicine, Immunology, Oncology +16

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Kristin M. Sanderson, Ronald Scotland, Peter P. Lee et al. · Journal of Clinical Oncology · 2004 · 433 citations

Life Sciences, Oncology, Pharmacokinetics +17